Ultragenyx Pharmaceutical Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Ultragenyx Pharmaceutical Inc. Return On Equity for the quarter ending September 30, 2024 was -187 %, a 46% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Return On Equity for 2023 was -370 %, a 200% decline from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Return On Equity for 2022 was -123 %, a 164% decline from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Return On Equity for 2021 was -46.8 %, a 95.9% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -370 -246 -200% Jan 1, 2023 Dec 31, 2023
2022 -123 -76.5 -164% Jan 1, 2022 Dec 31, 2022
2021 -46.8 -22.9 -95.9% Jan 1, 2021 Dec 31, 2021
2020 -23.9 +28.3 +54.2% Jan 1, 2020 Dec 31, 2020
2019 -52.2 -22.9 -78.2% Jan 1, 2019 Dec 31, 2019
2018 -29.3 +43.2 +59.6% Jan 1, 2018 Dec 31, 2018
2017 -72.5 -19.7 -37.4% Jan 1, 2017 Dec 31, 2017
2016 -52.8 -19.8 -60.2% Jan 1, 2016 Dec 31, 2016
2015 -32.9 +1.08 +3.17% Jan 1, 2015 Dec 31, 2015
2014 -34 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.